James Peyer, Director, 10% Owner at Sensei Biotherapeutics, Inc. (SNSE), bought 17,500 shares at $3.63 ($64K) on 2022-02-24, disclosed to the SEC on 2022-02-24.
Open-market purchase of $64k SNSE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.80 | 2,500 | $10K | 14.9% |
| 2 | $3.63 | 15,000 | $54K | 85.1% |
| Total | $3.65 avg | 17,500 | $64K | 100% |
| Filing → |
| SNSE | SELL | 2025-12-08 | $398K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $15K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $136K | — | Filing → |